{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:37Z","timestamp":1791357277264,"version":"4.3.1"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1038\/s41380-018-0123-4","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T06:44:42Z","timestamp":1532328282000},"page":"2355-2372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks"],"prefix":"10.1038","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3276-430X","authenticated-orcid":false,"given":"Santiago G.","family":"Lago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Tomasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9431-0653","authenticated-orcid":false,"given":"Geertje F.","family":"van Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan M.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7961-4467","authenticated-orcid":false,"given":"Frieder","family":"Haenisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jantine A.","family":"Broek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Suarez-Pinilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tillmann","family":"Ruland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Auyeug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olya","family":"Mikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolett","family":"Kabacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Arolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Baron-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicto","family":"Crespo-Facorro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Bahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,23]]},"reference":[{"key":"123_CR1","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/schbul\/sbm064","volume":"33","author":"FM Benes","year":"2007","unstructured":"Benes FM. Searching for unique endophenotypes for schizophrenia and bipolar disorder within neural circuits and their molecular regulatory mechanisms. Schizophr Bull. 2007;33:932\u20136.","journal-title":"Schizophr Bull"},{"key":"123_CR2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/496416a","volume":"496","author":"D Adam","year":"2013","unstructured":"Adam D. On the spectrum. Nature. 2013;496:6\u20138.","journal-title":"Nature"},{"key":"123_CR3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/mp.2015.35","volume":"20","author":"P Falkai","year":"2015","unstructured":"Falkai P, Rossner MJ, Schulze TG, Hasan A, Brz\u00f3zka MM, Malchow B, et al. Kraepelin revisited: schizophrenia from degeneration to failed regeneration. Mol Psychiatry. 2015;20:671\u20136.","journal-title":"Mol Psychiatry"},{"key":"123_CR4","doi-asserted-by":"crossref","first-page":"26R","DOI":"10.1203\/PDR.0b013e318212c196","volume":"69","author":"U Meyer","year":"2011","unstructured":"Meyer U, Feldon J, Dammann O. Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res. 2011;69:26R\u201333R.","journal-title":"Pediatr Res"},{"key":"123_CR5","unstructured":"American Psychiatric Association [APA]. The diagnostic and statistical manual of mental disorders. 4th ed., text revision (DSM-IV-TR). Author: Washington, DC, 2000."},{"key":"123_CR6","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1038\/sj.bjp.0707658","volume":"153","author":"E Schwarz","year":"2008","unstructured":"Schwarz E, Bahn S, The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders. Br J Pharmacol. 2008;153:S133\u20136.","journal-title":"Br J Pharmacol"},{"key":"123_CR7","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1176\/appi.ajp.2011.11010048","volume":"168","author":"EJ Bromet","year":"2011","unstructured":"Bromet EJ, Kotov R, Fochtmann LJ, Carlson Ga, Tanenberg-Karant M, Ruggero C, et al. Diagnostic shifts during the decade following first admission for psychosis. Am J Psychiatry. 2011;168:1186\u201394.","journal-title":"Am J Psychiatry"},{"key":"123_CR8","doi-asserted-by":"crossref","unstructured":"Lally J, MacCabe JH. Antipsychotic medication in schizophrenia: a review. Br Med Bull. 2015;114:169\u201379.","DOI":"10.1093\/bmb\/ldv017"},{"key":"123_CR9","doi-asserted-by":"crossref","first-page":"15067","DOI":"10.1038\/nrdp.2015.67","volume":"1","author":"RS Kahn","year":"2015","unstructured":"Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon TD, et al. Schizophrenia. Nat Rev Dis Prim. 2015;1:15067.","journal-title":"Nat Rev Dis Prim"},{"key":"123_CR10","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/ng.2711","volume":"45","author":"SH Lee","year":"2013","unstructured":"Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45:984\u201394.","journal-title":"Nat Genet"},{"key":"123_CR11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"S Ripke","year":"2014","unstructured":"Ripke S, Neale BM, Corvin A, Walters JTR, Farh K-H, Holmans PA, et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421\u20137.","journal-title":"Nature"},{"key":"123_CR12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature12975","volume":"506","author":"SM Purcell","year":"2014","unstructured":"Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature. 2014;506:185\u201390.","journal-title":"Nature"},{"key":"123_CR13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1192\/bjp.bp.113.131052","volume":"204","author":"E Rees","year":"2014","unstructured":"Rees E, Walters JTR, Georgieva L, Isles AR, Chambert KD, Richards AL, et al. Analysis of copy number variations at 15 schizophrenia-associated loci. Br J Psychiatry. 2014;204:108\u201314.","journal-title":"Br J Psychiatry"},{"key":"123_CR14","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(12)62129-1","volume":"381","author":"Cross-Disorder Group of the Psychiatric Genomics Consortium.","year":"2013","unstructured":"Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013;381:1371\u20139.","journal-title":"Lancet"},{"key":"123_CR15","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011;70:663\u201371.","journal-title":"Biol Psychiatry"},{"key":"123_CR16","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/mp.2010.71","volume":"16","author":"M Herberth","year":"2011","unstructured":"Herberth M, Koethe D, Cheng TMK, Krzyszton ND, Schoeffmann S, Guest PC, et al. Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients. Mol Psychiatry. 2011;16:848\u201359.","journal-title":"Mol Psychiatry"},{"key":"123_CR17","doi-asserted-by":"crossref","unstructured":"van Beveren NJM, Buitendijk GHS, Swagemakers S, Krab LC, R\u00f6der C, de Haan L et al. Marked reduction of AKT1 expression and deregulation of AKT1-associated pathways in peripheral blood mononuclear cells of schizophrenia patients. PLoS ONE. 2012;7:e32618.","DOI":"10.1371\/journal.pone.0032618"},{"key":"123_CR18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09915","volume":"473","author":"KJ Brennand","year":"2011","unstructured":"Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S, et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature. 2011;473:221\u20135.","journal-title":"Nature"},{"key":"123_CR19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nature15526","volume":"527","author":"J Mertens","year":"2015","unstructured":"Mertens J, Wang Q-W, Kim Y, Yu DX, Pham S, Yang B, et al. Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. Nature. 2015;527:95\u20139.","journal-title":"Nature"},{"key":"123_CR20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/mp.2016.220","volume":"22","author":"CM Sellgren","year":"2017","unstructured":"Sellgren CM, Sheridan SD, Gracias J, Xuan D, Fu T, Perlis RH. Patient-specific models of microglia-mediated engulfment of synapses and neural progenitors. Mol Psychiatry. 2017;22:170\u20137.","journal-title":"Mol Psychiatry"},{"key":"123_CR21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/stem.705","volume":"30","author":"K Martins-Taylor","year":"2012","unstructured":"Martins-Taylor K, Xu R-H. Concise review: genomic stability of human induced pluripotent stem cells. Stem Cells. 2012;30:22\u20137.","journal-title":"Stem Cells"},{"key":"123_CR22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.gde.2011.01.008","volume":"21","author":"PE Cundiff","year":"2011","unstructured":"Cundiff PE, Anderson SA. Impact of induced pluripotent stem cells on the study of central nervous system disease. Curr Opin Genet Dev. 2011;21:354\u201361.","journal-title":"Curr Opin Genet Dev"},{"key":"123_CR23","doi-asserted-by":"crossref","unstructured":"Falk A, Heine VM, Harwood AJ, Sullivan PF, Peitz M, Br\u00fcstle O et al. Modeling psychiatric disorders: from genomic findings to cellular phenotypes. Mol Psychiatry. 2016;21:1167\u201379.","DOI":"10.1038\/mp.2016.89"},{"key":"123_CR24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.pnpbp.2004.01.009","volume":"28","author":"A Gladkevich","year":"2004","unstructured":"Gladkevich A, Kauffman HF, Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:559\u201376.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"123_CR25","doi-asserted-by":"crossref","unstructured":"Lago SG, Tomasik J, van Rees GF, Steeb H, Cox DA, Rustogi N et al. Drug discovery in neuropsychiatric disorders using high-content single-cell screening of signaling network responses ex vivo. Submitted. 2018.","DOI":"10.1126\/sciadv.aau9093"},{"key":"123_CR26","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/mp.2016.50","volume":"21","author":"GB Rogers","year":"2016","unstructured":"Rogers GB, Keating DJ, Young RL, Wong ML, Licinio J, Wesselingh S. From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Mol Psychiatry. 2016;21:738\u201348.","journal-title":"Mol Psychiatry"},{"key":"123_CR27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46\u201356.","journal-title":"Nat Rev Neurosci"},{"key":"123_CR28","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neubiorev.2005.03.023","volume":"29","author":"AJ Dunn","year":"2005","unstructured":"Dunn AJ, Swiergiel AH, De Beaurepaire R. Cytokines as mediators of depression: what can we learn from animal studies? Neurosci Biobehav Rev. 2005;29:891\u2013909.","journal-title":"Neurosci Biobehav Rev"},{"key":"123_CR29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2004.06.028","volume":"118","author":"JM Irish","year":"2004","unstructured":"Irish JM, Hovland R, Krutzik PO, Perez OD, Bruserud \u00d8, Gjertsen BT, et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell. 2004;118:217\u201328.","journal-title":"Cell"},{"key":"123_CR30","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.jaci.2015.04.008","volume":"136","author":"WE O\u2019Gorman","year":"2015","unstructured":"O\u2019Gorman WE, Hsieh EWY, Savig ES, Gherardini PF, Hernandez JD, Hansmann L, et al. Single-cell systems-level analysis of human Toll-like receptor activation defines a chemokine signature in patients with systemic lupus erythematosus. J Allergy Clin Immunol. 2015;136:1326\u201336.","journal-title":"J Allergy Clin Immunol"},{"key":"123_CR31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nm.2670","volume":"18","author":"PF Sullivan","year":"2012","unstructured":"Sullivan PF. Puzzling over schizophrenia: schizophrenia as a pathway disease. Nat Med. 2012;18:210\u20131.","journal-title":"Nat Med"},{"key":"123_CR32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","volume":"1","author":"AL Hopkins","year":"2002","unstructured":"Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov. 2002;1:727\u201330.","journal-title":"Nat Rev Drug Discov"},{"key":"123_CR33","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.drudis.2013.07.001","volume":"18","author":"W Zheng","year":"2013","unstructured":"Zheng W, Thorne N, McKew JC. Phenotypic screens as a renewed approach for drug discovery. Drug Discov Today. 2013;18:1067\u201373.","journal-title":"Drug Discov Today"},{"key":"123_CR34","doi-asserted-by":"crossref","unstructured":"Krutzik PO, Nolan GP Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat Methods. 2006;3:361\u20138.","DOI":"10.1038\/nmeth872"},{"key":"123_CR35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nchembio.2007.59","volume":"4","author":"PO Krutzik","year":"2008","unstructured":"Krutzik PO, Crane JM, Clutter MR, Nolan GP. High-content single-cell drug screening with phosphospecific flow cytometry. Nat Chem Biol. 2008;4:132\u201342.","journal-title":"Nat Chem Biol"},{"key":"123_CR36","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association.","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134.","journal-title":"JAMA"},{"key":"123_CR37","first-page":"2","volume":"44","author":"PM Bossuyt","year":"2003","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Radiology. 2003;226:24\u20138.","journal-title":"Radiology"},{"key":"123_CR38","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1021\/acschembio.6b00306","volume":"11","author":"FF Wagner","year":"2016","unstructured":"Wagner FF, Bishop JA, Gale JP, Shi X, Walk M, Ketterman J, et al. Inhibitors of glycogen synthase kinase 3 with exquisite kinome-wide selectivity and their functional effects. ACS Chem Biol. 2016;11:1952\u201363.","journal-title":"ACS Chem Biol"},{"key":"123_CR39","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria, 2017."},{"key":"123_CR40","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28:882\u20133.","journal-title":"Bioinformatics"},{"key":"123_CR41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118\u201327.","journal-title":"Biostatistics"},{"key":"123_CR42","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ni.3368","volume":"17","author":"AringK Bj\u00f6rklund","year":"2016","unstructured":"Bj\u00f6rklund \u00c5K, Forkel M, Picelli S, Konya V, Theorell J, Friberg D, et al. The heterogeneity of human CD127+\u2009innate lymphoid cells revealed by single-cell RNA sequencing. Nat Immunol. 2016;17:451\u201360.","journal-title":"Nat Immunol"},{"key":"123_CR43","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10809","volume":"7","author":"LZ Yanez","year":"2016","unstructured":"Yanez LZ, Han J, Behr BB, Reijo Pera RA, Camarillo DB. Human oocyte developmental potential is predicted by mechanical properties within hours after fertilization. Nat Commun. 2016;7:10809.","journal-title":"Nat Commun"},{"key":"123_CR44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature14665","volume":"525","author":"A Van Keymeulen","year":"2015","unstructured":"Van Keymeulen A, Lee MY, Ousset M, Broh\u00e9e S, Rorive S, Giraddi RR, et al. Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity. Nature. 2015;525:119\u201323.","journal-title":"Nature"},{"key":"123_CR45","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nbt.3000","volume":"32","author":"S Li","year":"2014","unstructured":"Li S, \u0141abaj PP, Zumbo P, Sykacek P, Shi W, Shi L, et al. Detecting and correcting systematic variation in large-scale RNA sequencing data. Nat Biotechnol. 2014;32:888\u201395.","journal-title":"Nat Biotechnol"},{"key":"123_CR46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531:47\u201352.","journal-title":"Nature"},{"key":"123_CR47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cell.2014.12.032","volume":"160","author":"OJ Tamplin","year":"2015","unstructured":"Tamplin OJ, Durand EM, Carr LA, Childs SJ, Hagedorn EJ, Li P, et al. Hematopoietic stem cell arrival triggers dynamic remodeling of the perivascular niche. Cell. 2015;160:241\u201352.","journal-title":"Cell"},{"key":"123_CR48","doi-asserted-by":"crossref","first-page":"287ra71","DOI":"10.1126\/scitranslmed.aaa5993","volume":"7","author":"TE Sweeney","year":"2015","unstructured":"Sweeney TE, Shidham A, Wong HR, Khatri P. A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci Transl Med. 2015;7:287ra71.","journal-title":"Sci Transl Med"},{"key":"123_CR49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/ng.3457","volume":"48","author":"H Bai","year":"2015","unstructured":"Bai H, Harmanc\u0131 AS, Erson-Omay EZ, Li J, Co\u015fkun S, Simon M, et al. Integrated genomic characterization of IDH1-mutant glioma malignant progression. Nat Genet. 2016;48:59\u201366.","journal-title":"Nat Genet"},{"key":"123_CR50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57:289\u2013300.","journal-title":"J R Stat Soc B"},{"key":"123_CR51","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.1198704","volume":"332","author":"SC Bendall","year":"2011","unstructured":"Bendall SC, Simonds EF, Qiu P, Amir ED, Krutzik PO, Finck R, et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science. 2011;332:687\u201396.","journal-title":"Science"},{"key":"123_CR52","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nbt.2317","volume":"30","author":"B Bodenmiller","year":"2012","unstructured":"Bodenmiller B, Zunder ER, Finck R, Chen TJ, Savig ES, Bruggner RV, et al. Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat Biotechnol. 2012;30:858\u201367.","journal-title":"Nat Biotechnol"},{"key":"123_CR53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molmed.2012.11.001","volume":"19","author":"K Maiese","year":"2013","unstructured":"Maiese K, Chong ZZ, Shang YC, Wang S. MTOR: on target for novel therapeutic strategies in the nervous system. Trends Mol Med. 2013;19:51\u201360.","journal-title":"Trends Mol Med"},{"key":"123_CR54","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.cellsig.2005.02.003","volume":"17","author":"MP Delghandi","year":"2005","unstructured":"Delghandi MP, Johannessen M, Moens U. The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells. Cell Signal. 2005;17:1343\u201351.","journal-title":"Cell Signal"},{"key":"123_CR55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrd3955","volume":"12","author":"JF Chen","year":"2013","unstructured":"Chen J-F, Eltzschig HK, Fredholm BB. Adenosine receptors as drug targets \u2014 what are the challenges? Nat Rev Drug Discov. 2013;12:265\u201386.","journal-title":"Nat Rev Drug Discov"},{"key":"123_CR56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nri3403","volume":"13","author":"RJ Brownlie","year":"2013","unstructured":"Brownlie RJ, Zamoyska R. T cell receptor signalling networks: branched, diversified and bounded. Nat Rev Immunol. 2013;13:257\u201369.","journal-title":"Nat Rev Immunol"},{"key":"123_CR57","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.4049\/jimmunol.1101804","volume":"187","author":"ME Kalland","year":"2011","unstructured":"Kalland ME, Oberprieler NG, Vang T, Task\u00e9n K, Torgersen KM. T cell-signaling network analysis reveals distinct differences between CD28 and CD2 costimulation responses in various subsets and in the MAPK pathway between resting and activated regulatory T cells. J Immunol. 2011;187:5233\u201345.","journal-title":"J Immunol"},{"key":"123_CR58","doi-asserted-by":"crossref","unstructured":"Niiro H, Clark EA. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol. 2002;2:945-56.","DOI":"10.1038\/nri955"},{"key":"123_CR59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrd3937","volume":"12","author":"RM Young","year":"2013","unstructured":"Young RM, Staudt LM. Targeting pathological B cell receptor signalling in lymphoid malignancies. Nat Rev Drug Discov. 2013;12:229\u201343.","journal-title":"Nat Rev Drug Discov"},{"key":"123_CR60","first-page":"3","volume":"1","author":"R Davies","year":"2016","unstructured":"Davies R, Vogelsang P, Jonsson R, Appel S. An optimized multiplex flow cytometry protocol for the analysis of intracellular signaling in peripheral blood mononuclear cells. J Immunol Methods. 2016;436:58-63.","journal-title":"J Immunol Methods"},{"key":"123_CR61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrd2217","volume":"6","author":"Y Agid","year":"2007","unstructured":"Agid Y, Buzs\u00e1ki G, Diamond DM, Frackowiak R, Giedd J, Girault J-A, et al. How can drug discovery for psychiatric disorders be improved? Nat Rev Drug Discov. 2007;6:189\u2013201.","journal-title":"Nat Rev Drug Discov"},{"key":"123_CR62","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature07454","volume":"455","author":"SE Hyman","year":"2008","unstructured":"Hyman SE. A glimmer of light for neuropsychiatric disorders. Nature. 2008;455:890\u20133.","journal-title":"Nature"},{"key":"123_CR63","doi-asserted-by":"crossref","unstructured":"Fillman SG, Weickert TW, Lenroot RK, Catts SV, Bruggemann JM, Catts VS et al. Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca\u2019s area volume. Mol Psychiatry. 2016;21:1090-8.","DOI":"10.1038\/mp.2015.90"},{"key":"123_CR64","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/schbul\/sbv119","volume":"42","author":"AC Edwards","year":"2016","unstructured":"Edwards AC, Bigdeli TB, Docherty AR, Bacanu S, Lee D, de Candia TR, et al. Meta-analysis of positive and negative symptoms reveals schizophrenia modifier genes. Schizophr Bull. 2016;42:279\u201387.","journal-title":"Schizophr Bull"},{"key":"123_CR65","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1296","volume":"36","author":"ES Emamian","year":"2004","unstructured":"Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet. 2004;36:131\u20137.","journal-title":"Nat Genet"},{"key":"123_CR66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1503\/jpn.110011","volume":"37","author":"JM Beaulieu","year":"2012","unstructured":"Beaulieu J-M. A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health. J Psychiatry Neurosci. 2012;37:7\u201316.","journal-title":"J Psychiatry Neurosci"},{"key":"123_CR67","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/npp.2011.24","volume":"36","author":"JQ Pan","year":"2011","unstructured":"Pan JQ, Lewis MC, Ketterman JK, Clore EL, Riley M, Richards KR, et al. AKT kinase activity is required for lithium to modulate mood-related behaviors in mice. Neuropsychopharmacology. 2011;36:1397\u2013411.","journal-title":"Neuropsychopharmacology"},{"key":"123_CR68","unstructured":"Tobe BTD, Crain AM, Winquist AM, Calabrese B, Makihara H, Zhao WN, et al. Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis. Proc Natl Acad Sci USA. 2017;114:E4462-E4471."},{"key":"123_CR69","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1176\/appi.ajp.2015.15010019","volume":"172","author":"DW Volk","year":"2015","unstructured":"Volk DW, Chitrapu A, Edelson JR, Roman KM, Moroco AE, Lewis DA. Molecular mechanisms and timing of cortical immune activation in schizophrenia. Am J Psychiatry. 2015;172:1112\u201321.","journal-title":"Am J Psychiatry"},{"key":"123_CR70","doi-asserted-by":"crossref","first-page":"E46","DOI":"10.1503\/jpn.150195","volume":"41","author":"B Garc\u00eda-Bueno","year":"2016","unstructured":"Garc\u00eda-Bueno B, Gass\u00f3 P, MacDowell KS, Callado LF, Mas S, Bernardo M, et al. Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia. J Psychiatry Neurosci. 2016;41:E46\u201355.","journal-title":"J Psychiatry Neurosci"},{"key":"123_CR71","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/npp.2012.215","volume":"38","author":"P Roussos","year":"2013","unstructured":"Roussos P, Katsel P, Davis KL, Giakoumaki SG, Lencz T, Malhotra AK, et al. Convergent findings for abnormalities of the NF-\u03baB signaling pathway in schizophrenia. Neuropsychopharmacology. 2013;38:533\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"123_CR72","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.15","volume":"5","author":"K Malki","year":"2015","unstructured":"Malki K, Pain O, Tosto MG, Du Rietz E, Carboni L, Schalkwyk LC. Identification of genes and gene pathways associated with major depressive disorder by integrative brain analysis of rat and human prefrontal cortex transcriptomes. Transl Psychiatry. 2015;5:e519.","journal-title":"Transl Psychiatry"},{"key":"123_CR73","doi-asserted-by":"crossref","first-page":"e33598","DOI":"10.1371\/journal.pone.0033598","volume":"7","author":"YJ Liou","year":"2012","unstructured":"Liou Y-J, Wang H-H, Lee M-TM, Wang S-C, Chiang H-L, Chen C-C, et al. Genome-wide association study of treatment refractory schizophrenia in Han Chinese. PLoS ONE. 2012;7:e33598.","journal-title":"PLoS ONE"},{"key":"123_CR74","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1038\/tp.2013.100","volume":"3","author":"H Coon","year":"2013","unstructured":"Coon H, Darlington T, Pimentel R, Smith KR, Huff CD, Hu H, et al. Genetic risk factors in two Utah pedigrees at high risk for suicide. Transl Psychiatry. 2013;3:e325.","journal-title":"Transl Psychiatry"},{"key":"123_CR75","doi-asserted-by":"crossref","unstructured":"Kwon S-H, Han J-K, Choi M, Kwon Y-J, Kim SJ, Yi EH, et al. Dysfunction of microglial STAT3 alleviates depressive behavior via neuron-microglia interactions. Neuropsychopharmacology. 2017;42:2072-86.","DOI":"10.1038\/npp.2017.93"},{"key":"123_CR76","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mp.2012.110","volume":"18","author":"SG Fillman","year":"2013","unstructured":"Fillman SG, Cloonan N, Catts VS, Miller LC, Wong J, McCrossin T, et al. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry. 2013;18:206\u201314.","journal-title":"Mol Psychiatry"},{"key":"123_CR77","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","volume":"246","author":"JC Felger","year":"2013","unstructured":"Felger JC, Lotrich FE. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience. 2013;246:199\u2013229.","journal-title":"Neuroscience"},{"key":"123_CR78","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1017\/S1461145710001410","volume":"14","author":"B Dean","year":"2011","unstructured":"Dean B. Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies. Int J Neuropsychopharmacol. 2011;14:997\u20131012.","journal-title":"Int J Neuropsychopharmacol"},{"key":"123_CR79","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.neuron.2011.11.024","volume":"73","author":"CS Nicolas","year":"2012","unstructured":"Nicolas CS, Peineau S, Amici M, Csaba Z, Fafouri A, Javalet C, et al. The Jak\/STAT pathway is involved in synaptic plasticity. Neuron. 2012;73:374\u201390.","journal-title":"Neuron"},{"key":"123_CR80","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00441-014-1806-z","volume":"357","author":"MJ Berridge","year":"2014","unstructured":"Berridge MJ. Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia. Cell Tissue Res. 2014;357:477\u201392.","journal-title":"Cell Tissue Res"},{"key":"123_CR81","first-page":"e22925","volume":"2","author":"CS Nicolas","year":"2013","unstructured":"Nicolas CS, Amici M, Bortolotto ZA, Doherty A, Csaba Z, Fafouri A, et al. The role of JAK-STAT signaling within the CNS. JAKSTAT. 2013;2:e22925.","journal-title":"JAKSTAT"},{"key":"123_CR82","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/ejn.12412","volume":"39","author":"S Murase","year":"2014","unstructured":"Murase S, McKay RD. Neuronal activity-dependent STAT3 localization to nucleus is dependent on Tyr-705 and Ser-727 phosphorylation in rat hippocampal neurons. Eur J Neurosci. 2014;39:557\u201365.","journal-title":"Eur J Neurosci"},{"key":"123_CR83","volume":"5","author":"E Kong","year":"2015","unstructured":"Kong E, Sucic S, Monje FJ, Savalli G, Diao W, Khan D, et al. STAT3 controls IL6-dependent regulation of serotonin transporter function and depression-like behavior. Sci Rep. 2015;5:9009.","journal-title":"Sci Rep"},{"key":"123_CR84","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrneurol.2014.207","volume":"11","author":"X Hu","year":"2014","unstructured":"Hu X, Leak RK, Shi Y, Suenaga J, Gao Y, Zheng P, et al. Microglial and macrophage polarization\u2014new prospects for brain repair. Nat Rev Neurol. 2015;11:56\u201364.","journal-title":"Nat Rev Neurol"},{"key":"123_CR85","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1073\/pnas.0910658107","volume":"107","author":"JW Koo","year":"2010","unstructured":"Koo JW, Russo SJ, Ferguson D, Nestler EJ, Duman RS. Nuclear factor-B is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci USA. 2010;107:2669\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"123_CR86","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.biopsych.2008.03.017","volume":"64","author":"GE Miller","year":"2008","unstructured":"Miller GE, Chen E, Sze J, Marin T, Arevalo JMG, Doll R, et al. A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-\u03baB signaling. Biol Psychiatry. 2008;64:266\u201372.","journal-title":"Biol Psychiatry"},{"key":"123_CR87","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nm0197-20","volume":"3","author":"SA Lipton","year":"1997","unstructured":"Lipton SA. Janus faces of NF-kappa B: neurodestruction versus neuroprotection. Nat Med. 1997;3:20\u20132.","journal-title":"Nat Med"},{"key":"123_CR88","doi-asserted-by":"crossref","first-page":"e0121626","DOI":"10.1371\/journal.pone.0121626","volume":"10","author":"A Datta-Mitra","year":"2015","unstructured":"Datta-Mitra A, Kundu-Raychaudhuri S, Mitra A, Raychaudhuri SP. Cross talk between neuroregulatory molecule and monocyte: nerve growth factor activates the inflammasome. PLoS ONE. 2015;10:e0121626.","journal-title":"PLoS ONE"},{"key":"123_CR89","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2147\/NDT.S64236","volume":"10","author":"L Zhang","year":"2014","unstructured":"Zhang L, Zhao J. Profile of minocycline and its potential in the treatment of schizophrenia. Neuropsychiatr Dis Treat. 2014;10:1103\u201311.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"123_CR90","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/hup.2426","volume":"29","author":"K Oya","year":"2014","unstructured":"Oya K, Kishi T, Iwata N. Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials. Hum Psychopharmacol. 2014;29:483\u201391.","journal-title":"Hum Psychopharmacol"},{"key":"123_CR91","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrd4088","volume":"12","author":"G Miklossy","year":"2013","unstructured":"Miklossy G, Hilliard TS, Turkson J. Therapeutic modulators of STAT signalling for human diseases. Nat Rev Drug Discov. 2013;12:611\u201329.","journal-title":"Nat Rev Drug Discov"},{"key":"123_CR92","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jpsychires.2017.04.004","volume":"92","author":"W Zheng","year":"2017","unstructured":"Zheng W, Cai DB, Yang XH, Ungvari GS, Ng CH, M\u00fcller N, et al. Adjunctive celecoxib for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials. J Psychiatr Res. 2017;92:139\u201346.","journal-title":"J Psychiatr Res"},{"key":"123_CR93","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4088\/JCP.10r06823","volume":"73","author":"IE Sommer","year":"2012","unstructured":"Sommer IE, de Witte L, Begemann M, Kahn RS. Nonsteroidal anti-inflammatory drugs in schizophrenia. J Clin Psychiatry. 2012;73:414\u20139.","journal-title":"J Clin Psychiatry"},{"key":"123_CR94","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.pnpbp.2011.05.010","volume":"35","author":"CS Jernigan","year":"2011","unstructured":"Jernigan CS, Goswami DB, Austin MC, Iyo AH, Chandran A, Stockmeier CA, et al. The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:1774\u20139.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"123_CR95","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jad.2009.10.017","volume":"124","author":"P Yuan","year":"2010","unstructured":"Yuan P, Zhou R, Wang Y, Li X, Li J, Chen G, et al. Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia. J Affect Disord. 2010;124:164\u20139.","journal-title":"J Affect Disord"},{"key":"123_CR96","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.1073\/pnas.1505289112","volume":"112","author":"JM Dwyer","year":"2015","unstructured":"Dwyer JM, Maldonado-Avil\u00e9s JG, Lepack AE, DiLeone RJ, Duman RS. Ribosomal protein S6 kinase 1 signaling in prefrontal cortex controls depressive behavior. Proc Natl Acad Sci USA. 2015;112:6188\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"key":"123_CR97","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1017\/S1461145709991192","volume":"13","author":"SH Kim","year":"2010","unstructured":"Kim SH, Park HG, Kim HS, Ahn YM, Kim YS. Effects of neonatal MK-801 treatment on p70S6K-S6\/eIF4B signal pathways and protein translation in the frontal cortex of the developing rat brain. Int J Neuropsychopharmacol. 2010;13:1233\u201346.","journal-title":"Int J Neuropsychopharmacol"},{"key":"123_CR98","doi-asserted-by":"crossref","first-page":"E6290","DOI":"10.1073\/pnas.1610812113","volume":"113","author":"K Sawicka","year":"2016","unstructured":"Sawicka K, Pyronneau A, Chao M, Bennett MVL, Zukin RS. Elevated ERK\/p90 ribosomal S6 kinase activity underlies audiogenic seizure susceptibility in fragile X mice. Proc Natl Acad Sci USA. 2016;113:E6290\u2013E6297.","journal-title":"Proc Natl Acad Sci USA"},{"key":"123_CR99","first-page":"1","volume":"41","author":"A Bhattacharya","year":"2015","unstructured":"Bhattacharya A, Mamcarz M, Mullins C, Choudhury A, Boyle RG, Smith DG, et al. Targeting translation control with p70 S6 kinase 1 inhibitors to reverse phenotypes in fragile X syndrome mice. Neuropsychopharmacology. 2016;41:1991-2000.","journal-title":"Neuropsychopharmacology"},{"key":"123_CR100","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/sj.mp.4002135","volume":"14","author":"SR Engel","year":"2009","unstructured":"Engel SR, Creson TK, Hao Y, Shen Y, Maeng S, Nekrasova T, et al. The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement. Mol Psychiatry. 2009;14:448\u201361.","journal-title":"Mol Psychiatry"},{"key":"123_CR101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2015.00075","volume":"8","author":"A Biever","year":"2015","unstructured":"Biever A, Valjent E, Puighermanal E. Ribosomal protein S6 phosphorylation in the nervous system: from regulation to function. Front Mol Neurosci. 2015;8:75.","journal-title":"Front Mol Neurosci"},{"key":"123_CR102","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijdevneu.2013.02.008","volume":"31","author":"DM Feliciano","year":"2013","unstructured":"Feliciano DM, Lin TV, Hartman NW, Bartley CM, Kubera C, Hsieh L, et al. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits. Int J Dev Neurosci. 2013;31:667\u201378.","journal-title":"Int J Dev Neurosci"},{"key":"123_CR103","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/nn.3546","volume":"16","author":"M Costa-Mattioli","year":"2013","unstructured":"Costa-Mattioli M, Monteggia LM. mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat Neurosci. 2013;16:1537\u201343.","journal-title":"Nat Neurosci"},{"key":"123_CR104","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1523\/JNEUROSCI.23-19-07311.2003","volume":"23","author":"H Einat","year":"2003","unstructured":"Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L, et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci. 2003;23:7311\u20136.","journal-title":"J Neurosci"},{"key":"123_CR105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pnpbp.2012.10.025","volume":"40","author":"A Pereira","year":"2013","unstructured":"Pereira A, Zhang B, Malcolm P, Sundram S. Clozapine regulation of p90RSK and c-Fos signaling via the ErbB1-ERK pathway is distinct from olanzapine and haloperidol in mouse cortex and striatum. Prog Neuropsychopharmacol Biol Psychiatry. 2013;40:353\u201363.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"123_CR106","doi-asserted-by":"crossref","unstructured":"Ign\u00e1cio ZM, R\u00e9us GZ, Arent CO, Abelaira HM, Pitcher MR, Quevedo J. New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs. Br J Clin Pharmacol. 2016;82:1280-1290.","DOI":"10.1111\/bcp.12845"},{"key":"123_CR107","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jad.2013.11.014","volume":"156","author":"M Naughton","year":"2014","unstructured":"Naughton M, Clarke G, O\u2019Leary OF, Cryan JF, Dinan TG. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action. J Affect Disord. 2014;156:24\u201335.","journal-title":"J Affect Disord"},{"key":"123_CR108","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/2045125313507739","volume":"4","author":"C Caddy","year":"2014","unstructured":"Caddy C, Giaroli G, White TP, Shergill SS, Tracy DK. Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy. Ther Adv Psychopharmacol. 2014;4:75\u201399.","journal-title":"Ther Adv Psychopharmacol"},{"key":"123_CR109","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jad.2017.11.041","volume":"227","author":"J Dong","year":"2018","unstructured":"Dong J, Zhou Q, Wei Z, Yan S, Sun F, Cai X. Protein kinase A mediates scopolamine-induced mTOR activation and an antidepressant response. J Affect Disord. 2018;227:633\u201342.","journal-title":"J Affect Disord"},{"key":"123_CR110","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.neuropharm.2011.08.034","volume":"61","author":"H Koike","year":"2011","unstructured":"Koike H, Iijima M, Chaki S. Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists. Neuropharmacology. 2011;61:1419\u201323.","journal-title":"Neuropharmacology"},{"key":"123_CR111","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"122","author":"M Laplante","year":"2009","unstructured":"Laplante M, Sabatini DM. mTOR signaling at a glance. J Cell Sci. 2009;122:3589\u201394.","journal-title":"J Cell Sci"},{"key":"123_CR112","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","volume":"12","author":"A Oeckinghaus","year":"2011","unstructured":"Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-\u03baB signaling pathways. Nat Immunol. 2011;12:695\u2013708.","journal-title":"Nat Immunol"},{"key":"123_CR113","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3109\/08039488.2014.986761","volume":"69","author":"J Guo","year":"2015","unstructured":"Guo J, Liu C, Wang Y, Feng B, Zhang X. Role of T helper lymphokines in the immune-inflammatory pathophysiology of schizophrenia: Systematic review and meta-analysis. Nord J Psychiatry. 2015;69:364\u201372.","journal-title":"Nord J Psychiatry"},{"key":"123_CR114","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/acps.12211","volume":"129","author":"G Fond","year":"2014","unstructured":"Fond G, Hamdani N, Kapczinski F, Boukouaci W, Drancourt N, Dargel A, et al. Effectiveness and tolerance of anti-inflammatory drugs\u2019 add-on therapy in major mental disorders: a systematic qualitative review. Acta Psychiatr Scand. 2014;129:163\u201379.","journal-title":"Acta Psychiatr Scand"},{"key":"123_CR115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/schbul\/sbt139","volume":"40","author":"IE Sommer","year":"2014","unstructured":"Sommer IE, van Westrhenen R, Begemann MJH, de Witte LD, Leucht S, Kahn RS. Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update. Schizophr Bull. 2014;40:181\u201391.","journal-title":"Schizophr Bull"},{"key":"123_CR116","first-page":"227","volume":"3","author":"A Pereira","year":"2003","unstructured":"Pereira A, McLaren A, Bell WR, Copolov D, Dean B. Potential clozapine target sites on peripheral hematopoietic cells and stromal cells of the bone marrow. Pharmacogenomics J. 2003;3:227\u201334.","journal-title":"Pharm J"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0123-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0123-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0123-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T10:36:06Z","timestamp":1720434966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-018-0123-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,23]]},"references-count":116,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["123"],"URL":"https:\/\/doi.org\/10.1038\/s41380-018-0123-4","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,23]]},"assertion":[{"value":"13 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"J.T. was a consultant for Psynova Neurotech Ltd. until April 2016. S.G.L. was part funded by Psynova Neurotech Ltd. until October 2015. S.B is a director of Psynova Neurotech Ltd. and Psyomics Ltd. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}